Experiment 638242
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Ginkgo biloba (GINKGOACEAE) |
| Citation | KIDD,PM:. (1999). A REVIEW OF NUTRIENTS AND BOTANICALS IN THE INTEGRATIVE MANAGEMENT OF COGNITIVE DYSFUNCTION.. 4(3) |
| Amount utilized | |
| Compound isolated | |
| Disease | GINKGO'S BENEFITS FOR COGNITIVE DYSFUNCTION AND OTHER SYMPTOMS OF VASCULAR INSUFFICIENCY WITHSTOOD THE ANALYTICAL RIGOR OF A 1992 META-ANALYSIS. OUT OF THE 40 DOUBLE-BLIND TRIALS COMPILED FROM THE SCIENTIFIC LITERATURE, SIX BEST WERE EVALUATED. THESE SHOWED BENEFITS FOR AS FEW AS 17 PERCENT OF THE ELDERLY PATIENTS TO AS MANY AS 71 PERCENT OF THE YOUNGER PATIENTS, AT DOSAGES MOST TYPICALLY 160 MG PER DAY. SAFETY OVERALL WAS RATED QUITE GOOD. THIS, FOR COGNITIVE PROBLEMS LINKED TO VASCULAR INSUFFICIENCY, GBE STANDS WITH ITS LIMITATIONS AS AN AVAILABLE THERAPEUTIC TOOL. |
| Dose amount | 160.0 MG |
| Number | 2 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | ETOH(100%)EXT |
| Gender | GIVEN TO BOTH SEXES |